Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Harm Reduction topic
No spam. Unsubscribe anytime.
Senate advances needle-exchange bill citing disease-prevention benefits amid questions about encouraging drug use
Summary
House Bill 308 would authorize needle-exchange programs and link participants to education and rehabilitation through public-health agencies. Sponsors said exchanges reduce infections and provide data; some senators worried the policy could enable continued drug use. The bill was advanced for third reading with a roll call recorded.
Senator Shiozawa presented House Bill 308 as "a disease prevention bill," saying it would authorize syringe-exchange programs that provide sterile needles, required education and links to rehabilitation services through public-health agencies.
Supporters pointed to evidence that exchange programs reduce transmission of hepatitis C, hepatitis B and HIV and that connecting users to counseling and treatment can reduce downstream Medicaid costs; one sponsor noted treatment for hepatitis C can cost tens of thousands of dollars. Opponents asked whether easier access to sterile syringes would encourage drug use; sponsors responded that sterile needles reduce sharing, that users will obtain syringes regardless, and that formal programs allow tracking and reporting through public-health statisticians to evaluate outcomes.
Senator Fillmore asked why statute was necessary if programs require no appropriation; the sponsor said statutory authorization improves reporting and coordination with DPS and DOH. After questioning and debate, the chamber recorded a roll call showing 22 yay and 1 nay, and the bill was placed for third-reading consideration.
